Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AC Triazole and tetrazole derivatives
J02AC06 Oteseconazole
D11785 Oteseconazole (USAN/INN) <US>
USP drug classification [BR:br08302]
Antifungals
Oteseconazole
D11785 Oteseconazole (USAN/INN)
Drug groups [BR:br08330]
Antifungal
DG01523 Triazole antifungal
D11785 Oteseconazole
Drug classes [BR:br08332]
Antifungal
DG01523 Triazole antifungal
D11785 Oteseconazole
Antimicrobials [BR:br08307]
Antifungals
Ergosterol biosynthesis inhibitor
Triazole
D11785 Oteseconazole (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11785
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11785